Lilly gears up for ‘unprecedented year,’ touts promising pipeline
Following a banner year marked by the approval and launch of its diabetes drug Mounjaro (tirzepatide), Eli Lilly revealed at the 41st J.P. Morgan Healthcare Conference that it was preparing for another big year. Ceramic Fibre Blanket Insulation
In a fireside chat led by Anat Ashkenazi, Lilly’s executive vice president and chief financial officer, and Daniel M. Skovronsky, M.D., Ph.D., Lilly’s chief scientific and medical officer, the company detailed its busy year ahead, business forecasts and a robust pipeline that will support its long-term growth.
Ceramic Wool Blanket Product Launches and Pipeline Prospects